QC
TECX

Quadrature Capital’s Tectonic Therapeutic TECX Stock Holding History

Quadrature Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,014
Closed -$209K – 1956
2025
Q4 		$209K Sell
10,014
-16,258
-62% -$302K ﹤0.01% 960
2025
Q3 		$411K Buy
+26,272
New +$542K ﹤0.01% 585

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Quadrature Capital's TECX Position: Q1 2026 in Review

Quadrature Capital sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 10,014 shares — an estimated $209K sold.

Quadrature Capital first reported a position in TECX in Q3 2025 and held it in 2 quarters. The position peaked at $411K in Q3 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Quadrature Capital reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 10,014 Tectonic Therapeutic shares in Q1 2026, an estimated $209K.
  • Quadrature Capital first reported a position in Tectonic Therapeutic in Q3 2025 and held it in 2 quarters.
  • Quadrature Capital's Tectonic Therapeutic position peaked at $411K in Q3 2025.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.